Earlier this month, the Central Drugs Standard Control Organisations Subject Expert Committee (SEC) gave favourable recommendations to Torrent Pharmaceuticals for oral semaglutide tablets, and to MSN Laboratories and Natco Pharma for injectable semaglutide formulations, after reviewing Phase III clinical data
Am J Physiol Heart Circ Physiol 291:H2875H2883
Preclinical work has shown that cagrilintides weight-lowering effects are mediated primarily via AMY1 and AMY3 receptor subtypes, which are highly expressed in appetite-regulating regions of the brain
Water (Aqua), L-Ascorbic Acid, Dimethyl Isosorbide, Butylene Glycol, Glycerin, Pentylene Glycol, Glutathione, Phytic Acid, Panthenol, Gluconolactone, Centella Asiatica Extract, Phenoxyethanol, Sodium Benzoate, Sodium Hyaluronate, Menthol
improvement in FG, FI and related indices is achieved during DAs therapy